Paper19821482
Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
Yang MH and 7 others. Hepatology, 2009. Cited by 327 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Papers, record 19821482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19821482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
- PubMed
Topics28
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Neoplasm Metastasis | Major topic |
| Nuclear Proteins | Major topic |
| Transcription Factors | Major topic |
| Twist-Related Protein 1 | Major topic |
| Adult | |
| Aged | |
| Animals | |
| Cadherins | |
| Cell Differentiation | |
| Cell Line, Tumor | |
| Epithelial Cells | |
| Female | |
| Humans | |
| Male | |
| Mesoderm | |
| Mice | |
| Mice, Nude | |
| Middle Aged | |
| Retrospective Studies | |
| Snail Family Transcription Factors | |
| Transforming Growth Factor beta | |
| Transplantation, Heterologous | |
| Vimentin | |
| beta Catenin | |
| gamma Catenin |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01927354 | Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family. | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 19877297 | The epithelial-mesenchymal transition: fact or fiction in cancer? | https://conductscience.org/library/papers/19877297 |
Source PubMed
Cited by203
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 327 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41902186 | Hepatitis D Virus Pathogenesis: A Sense of Complications. | Viruses | 2026 | https://conductscience.org/library/papers/41902186 | PubMed |
| 41632098 | TGFβ1 Activates Lnc-APUE to Promote Tumor Metastasis via the Alu Element-Driven STAU1-Mediated Decay of CDH1 mRNA. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41632098 | PubMed |
| 41228242 | The Role of COL6A3 in Tumorigenesis, Metastasis, Diagnosis, and Disease Management. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41228242 | PubMed |
| 41121488 | Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels. | J Chin Med Assoc | 2025 | https://conductscience.org/library/papers/41121488 | PubMed |
| 40826252 | Exploration Biomarkers for Recurrence of Hepatocellular Carcinoma After Liver Transplantation Based on Bioinformatics Analysis. | Biochem Genet | 2026 | https://conductscience.org/library/papers/40826252 | PubMed |
| 40100307 | The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40100307 | PubMed |
| 39914372 | GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma. | Clin Mol Hepatol | 2025 | https://conductscience.org/library/papers/39914372 | PubMed |
| 39834395 | A five-plex Hepatic Oncochip reveals EMT triplet correlated with BAP31 in liver cancer. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39834395 | PubMed |
| 39415352 | Insight into prostate cancer osteolytic metastasis by RelB coordination of IL-8 and S100A4. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/39415352 | PubMed |
| 39261583 | Alpha lipoic acid diminishes migration and invasion in hepatocellular carcinoma cells through an AMPK-p53 axis. | Sci Rep | 2024 | https://conductscience.org/library/papers/39261583 | PubMed |
| 39223160 | A Boolean model explains phenotypic plasticity changes underlying hepatic cancer stem cells emergence. | NPJ Syst Biol Appl | 2024 | https://conductscience.org/library/papers/39223160 | PubMed |
| 39065699 | Comprehensive Review of Cyclamen: Development, Bioactive Properties, and Therapeutic Applications. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39065699 | PubMed |
| 38658567 | ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38658567 | PubMed |
| 37632029 | Cellular Factors Involved in the Hepatitis D Virus Life Cycle. | Viruses | 2023 | https://conductscience.org/library/papers/37632029 | PubMed |
| 37520960 | SP1/RNASEH2A accelerates the development of hepatocellular carcinoma by regulating EMT. | Heliyon | 2023 | https://conductscience.org/library/papers/37520960 | PubMed |
| 37495969 | Role of pelitinib in the regulation of migration and invasion of hepatocellular carcinoma cells via inhibition of Twist1. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37495969 | PubMed |
| 36675278 | Clinical Significance of Combined Epithelial-Mesenchymal Transition Markers Expression and Role of Rac1 in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675278 | PubMed |
| 36618329 | Role of microRNA-regulated cancer stem cells in recurrent hepatocellular carcinoma. | World J Hepatol | 2022 | https://conductscience.org/library/papers/36618329 | PubMed |
| 36010583 | Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors. | Cells | 2022 | https://conductscience.org/library/papers/36010583 | PubMed |
| 35875337 | Knockdown of SOX12 Expression Induced Apoptotic Factors is Associated with TWIST1 and CTNNB1 Expression in Human Acute Myeloid Leukemia Cells. | Int J Mol Cell Med | 2021 | https://conductscience.org/library/papers/35875337 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| SNAI1 | 6615 | PubTator's text mining | https://conductscience.org/library/genes/6615 | NCBI Gene |
| SNAI2 | 6591 | PubTator's text mining | https://conductscience.org/library/genes/6591 | NCBI Gene |
| TWIST1 | 7291 | PubTator's text mining | https://conductscience.org/library/genes/7291 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19821482
GET https://conductscience.org/api/papers/v1/19821482/cited_by?page=2